Evidence map›Paper›PMID 35269597›Full record

ReviewInternational journal of molecular sciences2022

Hydrogen Ion Dynamics as the Fundamental Link between Neurodegenerative Diseases and Cancer: Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis on Multiple Sclerosis.

Salvador Harguindey, Khalid Alfarouk, Julián Polo Orozco, Stephan J Reshkin, Jesús Devesa

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Stress-induced reduction of NaScience advances · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Salvador HarguindeyDivision of Oncology, Institute of Clinical Biology and Metabolism, 01004 Vitoria, Spain.ORCID 0000-0002-1725-757X
Khalid AlfaroukInstitute of Endemic Diseases, University of Khartoum, Khartoum 11111, Sudan.ORCID 0000-0001-8656-6117
Julián Polo OrozcoDivision of Oncology, Institute of Clinical Biology and Metabolism, 01004 Vitoria, Spain.
Stephan J ReshkinDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy.ORCID 0000-0001-9757-5908
Jesús DevesaScientific Direction, Foltra Medical Centre, 15886 Teo, Spain.ORCID 0000-0002-4153-2543

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pH-related metabolic paradigm has rapidly grown in cancer research and treatment. In this contribution, this recent oncological perspective has been laterally assessed for the first time in order to integrate neurodegeneration within the energetics of the cancer acid-base conceptual frame. At all levels of study (molecular, biochemical, metabolic, and clinical), the intimate nature of both processes appears to consist of opposite mechanisms occurring at the far ends of a physiopathological intracellular pH/extracellular pH (pHi/pHe) spectrum. This wide-ranging original approach now permits an increase in our understanding of these opposite processes, cancer and neurodegeneration, and, as a consequence, allows us to propose new avenues of treatment based upon the intracellular and microenvironmental hydrogen ion dynamics regulating and deregulating the biochemistry and metabolism of both cancer and neural cells. Under the same perspective, the etiopathogenesis and special characteristics of multiple sclerosis (MS) is an excellent model for the study of neurodegenerative diseases and, utilizing this pioneering approach, we find that MS appears to be a metabolic disease even before an autoimmune one. Furthermore, within this paradigm, several important aspects of MS, from mitochondrial failure to microbiota functional abnormalities, are analyzed in depth. Finally, and for the first time, a new and integrated model of treatment for MS can now be advanced.

Indexed as

Multiple SclerosisNeoplasmsNeurodegenerative DiseasesHumansMitochondriaProtonsProtonsneurodegenerative diseases—multiple sclerosisnew therapeutic options for multiple sclerosis and other neurodegenerative diseasespH in cancer and neurodegenerative diseases—cancer and neurodegeneration as opposed processes—metabolic etiopathogenesis of cancer and human neurodegenerative diseases

Identifiers

PMID35269597
PMCPMC8910484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.